| Print
BIOMERIEUX (BIM)
BIOMERIEUXThis share can be held in a Dealing accountSIPP
Company profile
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMerieux is headquartered in Marcy-l'Etoile, France.
Address
376, Chemin de l’Orme
Marcy l'Etoile
FRA
69280
Telephone
+33 478872237
Forecast key dates
| Name | Key Date |
|---|---|
| BioMerieux SA Second Quarter Earnings Results for 2026 | 2026-09-04T00:00:00 |
| BioMerieux SA Second Quarter Earnings Conference Call for 2026 | 2026-09-04T00:00:00 |
| BioMerieux SA Annual General Meeting for 2026 | 2026-05-15T09:00:00 |
| BioMerieux SA Annual Report for 2025 | 2026-03-24T00:00:00 |
| BioMerieux SA First Quarter Earnings Conference Call for 2025 | 2026-03-06T13:00:00 |
| BioMerieux SA Fourth Quarter Earnings Conference Call for 2025 | 2026-03-06T13:00:00 |
| BioMerieux SA First Quarter Earnings Results for 2025 | 2026-03-06T00:00:00 |
| BioMerieux SA Fourth Quarter Earnings Results for 2025 | 2026-03-06T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| BioMerieux SA Third Quarter Earnings Results for 2025 | 2025-10-30T00:00:00 |
| BioMerieux SA Third Quarter Earnings Conference Call for 2025 | 2025-10-30T00:00:00 |
| BioMerieux SA Second Quarter Earnings Result for 2025 | 2025-09-04T00:00:00 |
| BioMerieux SA Second Quarter Earnings Conference Call for 2025 | 2025-09-04T00:00:00 |
| BioMerieux SA Annual General Meeting for 2025 | 2025-05-15T09:00:00 |
| BioMerieux SA Annual Report for 2024 | 2025-03-24T00:00:00 |
| BioMerieux SA Fourth Quarter Earnings Conference Call for 2024 | 2025-03-07T13:00:00 |
| BioMerieux SA Fourth Quarter Earnings Result for 2024 | 2025-03-07T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.